[Letter: An undesirable effect of beta-stimulating agents? Outbreak of an acute psychiatric symptomatology in mental patients].
D000208:Acute Disease; D000318:Adrenergic beta-Agonists / Q000009:adverse effects* / Q000627:therapeutic use; D000328:Adult; D000420:Albuterol / Q000009:adverse effects; D003863:Depression / Q000139:chemically induced; D005260:Female; D006212:Hallucinations / Q000139:chemically induced; D006801:Humans; D007556:Isoxsuprine / Q000009:adverse effects; D001523:Mental Disorders / Q000150:complications*; D007752:Obstetric Labor, Premature / Q000188:drug therapy; D010627:Phenethylamines / Q000009:adverse effects; D011247:Pregnancy; D011248:Pregnancy Complications
D000318:Adrenergic beta-Agonists; D010627:Phenethylamines; D000420:Albuterol; D007556:Isoxsuprine
Effet indésirable de dérivés bêta-stimulants? Emergence d'une symptomatologie psychiatrique alguë chez des malades mentaux